Abstract
PurposeTo explore the effects of group singing therapy on depression symptoms and quality of life of patients with stable chronic obstructive pulmonary disease (COPD).MethodsPatients with COPD were randomly allocated to intervention (n = 30) and control groups (n = 30). The intervention group received group singing therapy once a week for 24 sessions along with routine health education, whereas the control group only received the routine health education. All patients were administered the Hospital Anxiety and Depression Scale depression subscale (HADS-D) and the Clinical COPD Questionnaire (CCQ). Data were collected at baseline and at 1, 3, and 6 months.ResultsFifty-six participants completed this trial. Significant between-group differences were observed with respect to the main effect of group and time as well as the effect of group × time interaction on HADS-D score. The HADS-D score was significantly improved 1, 3, 6 months after group singing therapy. The CCQ total scores were significantly different between the two groups with respect to the main effect of group and time and the group × time interaction effect. Significantly better CCQ was detected in the intervention group at 3 months and 6 months after intervention.ConclusionsGroup singing therapy reduces depressive symptoms and improves the quality of life of patients with stable COPD.
Highlights
Chronic obstructive pulmonary disease (COPD) is characterized by progressive and irreversible airflow obstruction, and is associated with high morbidity and mortality [1]
Owing to the considerable overlap between the somatic symptoms of depression and symptoms of COPD, the presence of this mental disease is liable to be unrecognized by COPD patients and more likely to be missed by their physicians as compared to patients with other comorbidities or depression alone [6]
The total scores in the experimental group were significantly lower than those in the control group at different time-points; these findings indicate a beneficial effect of group singing therapy on health-related quality of life (HRQL) of patients with COPD
Summary
Chronic obstructive pulmonary disease (COPD) is characterized by progressive and irreversible airflow obstruction, and is associated with high morbidity and mortality [1]. COPD patients are more commonly affected by depression as compared to patients with other chronic conditions [2]. Owing to the considerable overlap between the somatic symptoms of depression and symptoms of COPD, the presence of this mental disease is liable to be unrecognized by COPD patients and more likely to be missed by their physicians as compared to patients with other comorbidities or depression alone [6]. The stigma of mental ill-health can prevent people who may be suffering from depression from seeking care from a psychologist. Owing to these factors, depression may remain undetected, undertreated, or even untreated in patients with COPD.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
